ExodusPoint Capital Management’s ChemoCentryx, Inc. CCXI Stock Holding History

ExodusPoint Capital Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-105,124	Closed	-$2.6M	–	2481
2022 Q2	$2.6M	Buy	105,124 +11,155	+12%	+$246K	0.03%	667
2022 Q1	$2.36M	Sell	93,969 -103,226	-52%	-$2.9M	0.03%	698
2021 Q4	$7.18M	Buy	+197,195	New	+$6.92M	0.07%	309
2021 Q3	–	Sell	-35,616	Closed	-$477K	–	2859
2021 Q2	$477K	Buy	+35,616	New	+$877K	0.01%	1474
2020 Q3	–	Sell	-40,031	Closed	-$2.3M	–	2375
2020 Q2	$2.3M	Buy	+40,031	New	+$2.18M	0.06%	374
2019 Q2	–	Sell	-10,361	Closed	-$144K	–	1406
2019 Q1	$144K	Buy	+10,361	New	+$118K	0.01%	595

Other funds holding CCXI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

ExodusPoint Capital Management's CCXI Position: Q3 2022 in Review

ExodusPoint Capital Management sold out of ChemoCentryx, Inc. (CCXI) in Q3 2022, closing a stake of 105,124 shares — an estimated $2.6M sold.

ExodusPoint Capital Management first reported a position in CCXI in Q1 2019 and held it in 6 quarters. The position peaked at $7.18M in Q4 2021. 217 funds tracked by Wall St. Rank hold CCXI as of Q3 2022.

ExodusPoint Capital Management reported no remaining ChemoCentryx, Inc. position as of Q3 2022 after selling out during the quarter.
ExodusPoint Capital Management sold 105,124 ChemoCentryx, Inc. shares in Q3 2022, an estimated $2.6M.
ExodusPoint Capital Management first reported a position in ChemoCentryx, Inc. in Q1 2019 and held it in 6 quarters.
ExodusPoint Capital Management's ChemoCentryx, Inc. position peaked at $7.18M in Q4 2021.
217 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2022.

Based on ExodusPoint Capital Management's 13F filing for Q3 2022, filed 10 Nov 2022.